F
SCMP

FolioMetrix’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

FolioMetrix’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		$1.06M Buy
61,800
+42,500
+220% +$737K 0.44% 42
2015
Q1 		$300K Buy
+19,300
New +$299K 0.15% 114

Other funds holding SCMP

GIM
Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
KAM
Krensavage Asset Management New York $263M AUM 66.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

FolioMetrix's SCMP Position: Q2 2015 in Review

FolioMetrix increased its Sucampo Pharmaceuticals, Inc. (SCMP) stake by 220% in Q2 2015, buying an estimated $737K and bringing the position to 61,800 shares worth $1.06M. The position accounts for 0.44% of the portfolio, ranked #42.

FolioMetrix first reported a position in SCMP in Q1 2015 and has held it in 2 quarters since. 130 funds tracked by Wall St. Rank hold SCMP as of Q2 2015.

  • FolioMetrix held 61,800 shares of Sucampo Pharmaceuticals, Inc. worth $1.06M as of Q2 2015.
  • FolioMetrix bought 42,500 Sucampo Pharmaceuticals, Inc. shares in Q2 2015, an estimated $737K.
  • Sucampo Pharmaceuticals, Inc. made up 0.44% of FolioMetrix's portfolio in Q2 2015, its #42 holding.
  • FolioMetrix first reported a position in Sucampo Pharmaceuticals, Inc. in Q1 2015 and has held it in 2 quarters since.
  • 130 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q2 2015.

Based on FolioMetrix's 13F filing for Q2 2015, filed 5 Aug 2015.